CVS Health Stock-Based Compensation 2010-2024 | CVS

CVS Health annual/quarterly stock-based compensation history and growth rate from 2010 to 2024. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
  • CVS Health stock-based compensation for the quarter ending December 31, 2024 was $540M, a 8.16% decline year-over-year.
  • CVS Health stock-based compensation for the twelve months ending December 31, 2024 was $1.350B, a 7.47% decline year-over-year.
  • CVS Health annual stock-based compensation for 2024 was $0.54B, a 8.16% decline from 2023.
  • CVS Health annual stock-based compensation for 2023 was $0.588B, a 31.54% increase from 2022.
  • CVS Health annual stock-based compensation for 2022 was $0.447B, a 7.64% decline from 2021.
CVS Health Annual Stock-Based Compensation
(Millions of US $)
2024 $540
2023 $588
2022 $447
2021 $484
2020 $400
2019 $453
2018 $280
2017 $234
2016 $222
2015 $230
2014 $165
2013 $141
2012 $132
2011 $135
2010 $150
2009 $165
Sector Industry Market Cap Revenue
Medical Medical Services $75.952B $372.809B
CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $134.417B 25.21
Elevance Health (ELV) United States $84.565B 10.91
Cencora (COR) United States $54.132B 18.82
DiDi Global (DIDIY) China $21.231B 32.22
Natera (NTRA) United States $20.665B 0.00
BioMerieux (BMXMF) France $15.263B 0.00
Solventum (SOLV) United States $12.308B 13.03
EUROFINS SCIENT (ERFSF) Luxembourg $12.132B 0.00
Doximity (DOCS) United States $11.108B 57.77
CochLear (CHEOY) Australia $11.097B 0.00
Revvity (RVTY) United States $10.729B 18.46
ICON (ICLR) Ireland $10.678B 9.93
Viatris (VTRS) United States $9.882B 3.40
Avantor (AVTR) United States $8.756B 12.72
HealthEquity (HQY) United States $8.482B 41.73
Medpace Holdings (MEDP) United States $8.385B 22.27
Sonic Healthcare (SKHHY) Australia $8.090B 0.00
Charles River Laboratories (CRL) United States $6.825B 13.37
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.093B 37.89
Bausch + Lomb (BLCO) Canada $4.082B 24.06
Sotera Health (SHC) United States $3.636B 20.66
Alignment Healthcare (ALHC) United States $2.950B 0.00
Surgery Partners (SGRY) United States $2.918B 37.95
Concentras Parent (CON) United States $2.739B 15.83
Organon (OGN) United States $2.090B 2.22
Ardent Health Partners (ARDT) United States $2.084B 8.88
Premier (PINC) United States $2.056B 14.07
Progyny (PGNY) United States $1.874B 41.24
GeneDx Holdings (WGS) United States $1.696B 65.33
PACS (PACS) United States $1.666B 0.00
GoodRx Holdings (GDRX) United States $1.638B 30.50
Teladoc Health (TDOC) United States $1.288B 0.00
Pediatrix Medical (MD) United States $1.219B 9.27
Agilon Health (AGL) United States $1.105B 0.00
Establishment Labs Holdings (ESTA) $1.054B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.892B 13.93
Nutex Health (NUTX) United States $0.884B 13.36
AMN Healthcare Services Inc (AMN) United States $0.833B 7.80
QDM (QDMI) Hong Kong, SAR China $0.691B 0.00
Embecta (EMBC) United States $0.677B 4.56
InnovAge Holding (INNV) United States $0.554B 0.00
Enhabit (EHAB) United States $0.536B 44.08
Auna S.A (AUNA) Luxembourg $0.514B 13.61
Sonida Senior Living (SNDA) United States $0.496B 0.00
LifeMD (LFMD) United States $0.434B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.358B 0.00
SBC Medicals (SBC) United States $0.348B 0.00
Performant Healthcare (PHLT) United States $0.203B 0.00
Beauty Health (SKIN) United States $0.185B 0.00
Oncology Institute (TOI) United States $0.179B 0.00
DocGo (DCGO) United States $0.143B 23.33
So-Young (SY) China $0.086B 0.00
Sera Prognostics (SERA) United States $0.085B 0.00
OncoCyte (OCX) United States $0.074B 0.00
Ascend Wellness Holdings (AAWH) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.056B 0.00
KindlyMD (KDLY) United States $0.046B 0.00
Basel Medical Group (BMGL) Singapore $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
Pheton Holdings (PTHL) China $0.033B 0.00
Biodesix (BDSX) United States $0.032B 0.00
ModivCare (MODV) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.012B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00